Provided by Tiger Trade Technology Pte. Ltd.

Repligen

136.44
+3.812.87%
Post-market: 136.440.00000.00%18:43 EST
Volume:767.01K
Turnover:104.48M
Market Cap:7.68B
PE:5.36K
High:140.75
Open:133.97
Low:133.39
Close:132.63
52wk High:175.77
52wk Low:102.97
Shares:56.29M
Float Shares:52.66M
Volume Ratio:0.85
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0254
EPS(LYR):-0.4600
ROE:0.08%
ROA:1.30%
PB:3.69
PE(LYR):-296.61

Loading ...

Repligen Corporation to Announce Fourth Quarter and Full Year Financial Results

Reuters
·
Feb 10

Q/C Technologies Inc. Files Initial Beneficial Ownership Statement for Director Chelsea Sierra Voss

Reuters
·
Jan 31

Q/C Technologies Appoints AI Expert Chelsea Voss to Board

Reuters
·
Jan 26

Q/C Technologies Appoints Chelsea Voss to Board of Directors

Reuters
·
Jan 20

Repligen Is Maintained at Buy by UBS

Dow Jones
·
Jan 17

UBS Adjusts Price Target on Repligen to $200 From $190, Maintains Buy Rating

MT Newswires Live
·
Jan 16

Repligen Corporation Files Initial Statement of Beneficial Ownership for Chief Product Officer Brian Robb

Reuters
·
Jan 13

Repligen Appoints Martin Madaus as Board Chair as Tony Hunt Retires

Reuters
·
Jan 06

Repligen Executive Chair Tony Hunt to Retire; DR. Martin D. Madaus Elected Chair

THOMSON REUTERS
·
Jan 06

Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit

Simply Wall St.
·
Dec 19, 2025

Repligen Director Karen A. Dawes Reports Sale of Common Shares

Reuters
·
Dec 19, 2025

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

GlobeNewswire
·
Dec 18, 2025

Repligen Unveils Next-Generation Chromatography Resins

Reuters
·
Dec 16, 2025

Repligen Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Dec 16, 2025

Q/C Technologies Appoints Martin Shkreli as Strategic Advisor

Reuters
·
Dec 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's Secret

Reuters
·
Dec 05, 2025

U.S. RESEARCH ROUNDUP-BankUnited, Chevron, Paychex

Reuters
·
Dec 01, 2025

Repligen CEO Olivier Loeillot Reports Disposal of Common Shares

Reuters
·
Nov 27, 2025

Repligen Corporation to Present at Evercore Healthcare Conference

GlobeNewswire
·
Nov 26, 2025

A Look at Repligen’s (RGEN) Valuation Following Recent Share Price Gains

Simply Wall St.
·
Nov 24, 2025